B

Bellicum Pharmaceuticals, Inc.

126 employees

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

Basic info

Industry

biotechnology

Sectors

Biotechnology

Health Diagnostics

Health Care

Therapeutics

Bone Marrow Transplantation

Oncology

Vaccines

Cell Therapy

Date founded

2003

Funding rounds raised

Total raised

$55M

from 9 investors over 9 rounds

B

Bellicum Pharmaceuticals, Inc. raised $17M on November 17, 2016

Investors: Cancer Prevention and Research Institute of Texas

B

Bellicum Pharmaceuticals, Inc. raised undisclosed on January 1, 2015

Investors: Hercules Capital, Inc.

B

Bellicum Pharmaceuticals, Inc. raised $55M on August 27, 2014

Investors: Jennison Associates LLC, AJU IB INVESTMENT, venBio Partners, Ridgeback Capital Management LLC, RA Capital Management, L.P., Perceptive Advisors and Redmile Group